RxDoctor Payments DataLook up a doctor →

Robert Reindollar

Gastroenterology · Salisbury, NCNPI 1851382287

Payments from drug & device makers

$2,489,838in general payments, 2019–2025

Across 691 payments — averaging $3603.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intercept Pharmaceuticals, Inc.$1.8M
  • Gilead$256K
  • AbbVie$221K
  • Bristol Myers Squibb$197K
  • Intercept Pharma Europe Ltd.$26K
  • Merck$500
  • plus $2K from 15 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intercept Pharmaceuticals, Inc.271$1,786,498
Gilead131$256,273
AbbVie199$221,281
Bristol Myers Squibb17$197,254
Intercept Pharma Europe Ltd.2$26,493
Merck1$500
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC22$440
Madrigal Pharmaceuticals9$336
Takeda Pharmaceuticals U.S.A., Inc.9$198
Johnson & Johnson9$190
Daiichi Sankyo Inc.5$87
Novo Nordisk2$52
Ironwood Pharmaceuticals, Inc2$49
Ardelyx, Inc.3$46
Pfizer2$37
Nestle Healthcare Nutrition Inc.2$29
Orexo US, Inc.1$19
Ferring Pharmaceuticals Inc.1$16
Organon1$14
Evoke Pharma, Inc.1$14
Sanofi1$14

How this compares

$2,489,838 in reported general payments places this provider in the 95th percentile of 610 gastroenterology providers in North Carolina.

See all gastroenterology providers in North Carolina →

Other gastroenterology in Salisbury

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →